# UARK 2003-33, Total Therapy III

> **NCT00081939** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 303 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade
- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT00081939
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081939, "UARK 2003-33, Total Therapy III". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00081939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*